Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8441653 | European Journal of Cancer | 2016 | 10 Pages |
Abstract
We have identified novel prognostic factors for hepatoblastoma, as well as confirmed established factors, that will be used to develop a future common global risk stratification system. The mechanics of developing the globally accessible web-based portal, building and refining the database, and performing this first statistical analysis has laid the foundation for future collaborative efforts. This is an important step for refining of the risk based grouping and approach to future treatment stratification, thus we think our collaboration offers a template for others to follow in the study of rare tumors and diseases.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Piotr Czauderna, Beate Haeberle, Eiso Hiyama, Arun Rangaswami, Mark Krailo, Rudolf Maibach, Eugenia Rinaldi, Yurong Feng, Daniel Aronson, Marcio Malogolowkin, Kenichi Yoshimura, Ivo Leuschner, Dolores Lopez-Terrada, Tomoro Hishiki, Giorgio Perilongo,